ABSTRACT. Acute pancreatitis (AP) has a fast onset and progression, which lead to an unfavorable prognosis. Therefore, the development of novel drugs for its treatment is critical. As a homologous derivative of resveratrol, pterostilbene exerts a variety of effects including anti-inflammatory, antioxidant, and antitumor effects. This study investigated the potential of pterostilbene for treatment of severe AP (SAP) and related mechanisms. Effects of pterostilbene were evaluated in a Wistar rat model of AP. Serum levels of amylase (AMY), creatinine (Cr), and alanine aminotransferase (ALT) were quantified. Furthermore, serum levels of tumor necrosis factor (TNF)-a and interleukin (IL)-1b were quantified using enzyme-linked immunosorbent assay. Nuclear factor (NF)-kB expression in pancreatic tissues was quantified by realtime PCR and western blotting. The production of reactive oxygen species (ROS) was determined using a spectrometer, while superoxide dismutase (SOD) activity was assayed. In the AP rat model, the expression of inflammatory markers TNF-a and IL-1b, expression of NF-kB, and serum indices (AMY, Cr, and ALT) increased compared to the corresponding levels in the control group (P < 0.05). Pterostilbene reduced serum levels of TNF-a and IL-1b; decreased NF-kB gene expression, serum indices, and ROS generation; and increased SOD activity in a dose-dependent manner. In conclusion, pterostilbene can alleviate SAP-induced tissue damage by decreasing the inflammatory response and by promoting antioxidation leading to the protection of pancreatic tissues.
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INTRODUCTION
Acute pancreatitis (AP) is the sudden inflammation of the pancreas and has a fast onset (Gooshe et al., 2015) . The early manifestations of AP are atypical, mainly including acute upper abdominal pain, nausea, vomiting, and elevated amylase level (Chanana et al., 2015) . Mild AP only involves pancreatic edema, and can self-heal in a short time. However, severe AP (SAP) can lead to necrosis of tissues adjacent to the pancreas and to multiple-organ failure in a short time. Due to the fast progression and lack of effective treatment, SAP has unfavorable prognosis and an extremely high mortality rate (Dragoman et al., 2015; Kayar et al., 2015) . The pathological features of AP mainly result from the activation of trypsin inside the pancreas, leading to auto-digestion, tissue edema, hemorrhage, and necrotic inflammation (Murata et al., 2015; Usborne et al., 2015) . AP may be induced by various factors including bile duct obstruction, alcohol abuse, thrombosis (of lymph vessel, vein, or artery), traumatic injury, and infection. Inflammation is believed to be the initiating factor of AP. It leads to an abnormal activation of trypsin inside the pancreatic acinar cells, which causes systemic reactions (Ehehalt et al., 2015; Nasa et al., 2015) . Therefore, the identification of new drugs that are effective against SAP is of great importance for alleviating disease progression and for improving survival rates and prognosis (Puiggròs et al., 2015) .
Resveratrol has multiple activities including antioxidant, anti-inflammatory, antibacterial, antitumor, vasodilation modulator, and platelet aggregation inhibitor. In addition, it regulates lipoprotein metabolism and improves the body's immune functions (Yar et al., 2011; Jagadeb et al., 2014; Shimoda et al., 2015) . Pterostilbene [(E)-3,5-dimethyl-4-hydroxyl phenyl ethylene] is a 3,5-dimethyl derivative of resveratrol. It is one among the non-flavonoid polyphenol compounds that are found in grapes, nuts, strawberry, Guangxi dragon's blood, and propolia (Hsiao et al., 2014; Sato et al., 2014) . Pterostilbene has activities that are similar to those of resveratrol, and shows multiple activities including antifungal, antiproliferative, antioxidant, anti-inflammatory, and antilipidemic activities. However, it has higher bioactivity than resveratrol and mainly exerts anti-inflammatory, antioxidant, and antitumor activities. Studies have shown its efficacy in treating multiple diseases including Alzheimer's disease, cardiovascular disorders, brain trauma, cancer, and hypercholesterolemia (Pan et al., 2014; Saw et al., 2014) . Therefore, this study investigated the protective role of pterostilbene against SAP and related mechanisms.
MATERIAL AND METHODS

Animal model
Healthy male Wistar rats (N = 40, age = 2 months, body weight = 250 g) were purchased from the Laboratory Animal Unit of Medicine School of Zhejiang University and were kept in an SPF facility. The room temperature was maintained at 21° ± 1°C, and the relative humidity at 50 to 70%. A 12-h light/12-h dark cycle was maintained throughout the study.
All experimental procedures were approved by the Animal Ethics Committee of Medicine School of Zhejiang University. All animal experiments followed the animal care guidelines of Zhejiang University.
Animals were randomly divided into 4 groups (N = 10): control, SAP, low pterostilbene (20 mg/kg), and high pterostilbene (40 mg/kg). SAP was induced in all groups except the control group. For development of SAP model, the rats were fasted for 12 h, and anesthetized by intraperitoneal injection of 10% chloral hydrate. A median incision was made in the upper abdomen to expose the duodenum and biliary pancreatic duct that was then clipped on the proximal site of the hepatic portal. A retrograde puncture was made on the biliary pancreatic duct via duodenal papilla. Subsequently, freshly prepared 5% sodium taurocholate solution (Sigma, USA) was perfused into the biliary pancreatic duct at 0.1 mL/min to reach an internal concentration of 0.1 mg/100 g as previously described (Wang et al., 2015b ). The biliary duct was then clipped for 5 min to immerse all pancreatic lobes into sodium taurocholate solutions. In the control group, a similar surgical procedure was performed; however, equal volume of saline was applied instead of sodium taurocholate solution. The two treatment groups received 20 or 40 mg/kg pterostilbene (Gómez-Zorita et al., 2015) before surgery.
Determination of serum AMY, Cr and ALT
Blood samples were collected from the abdominal aorta. After incubation at room temperature for 30 min, serum was collected by centrifugation at 2000 g for 10 min. Serum levels of AMY, Cr, and ALT were determined using an automatic biochemical analyzer.
Enzyme-linked immunosorbent assay (ELISA)
Serum samples were assayed for inflammatory cytokines (TNF-a and IL-1b) using ELISA kits. Briefly, serially diluted standards and samples were added to the 96-well plates in triplicate. Enzyme-labeling reagents (50 mL) were then added to each well and plates were incubated for 30 min at 37°C. Subsequently, chromogenic substrates A and B (50 mL each) were added and plates were incubated in the dark at 37°C for 10 min to develop signals. The reaction was quenched by addition of a stopping buffer. Plates were read on a microplate reader (BD, USA) to record the optical density values at 450 nm. A standard curve was used to determine the sample values using linear regression.
Real-time PCR
Pancreatic tissues were collected, rinsed in PBS, and homogenized on ice. The mRNA was extracted using Trizol reagent (Invitrogen, USA) and converted to cDNA using specific primers (Table 1) . Real-time PCR was performed to detect the expression of target genes under the following conditions: 95°C for 1 min; followed by 35 cycles of denaturing at 90°C for 30 s; annealing at 58°C for 50 s; and elongation at 72°C for 35 s. Fluorescence signals were detected and the Ct values were analyzed with reference to GAPDH. Relative expression was determined by the 2 -∆Ct method. 
Western blotting
Pancreatic tissues were homogenized and a lysis buffer was added to extract the total proteins. The homogenized tissue samples were then ruptured by ultrasonication and centrifuged at 10,000 g for 15 min. Proteins were collected and stored at -20°C. For western blotting, proteins were resolved by 10% SDS-PAGE, and then transferred to a PVDF membrane (Pall Life, USA). Non-specific binding sites were blocked by incubation in 5% non-fat milk powder for 2 h. The membranes were then incubated with anti-NF-kB monoclonal antibody (1:1000, Cell Signaling, USA) overnight. Subsequently, the membranes were incubated with goat anti-rabbit IgG (1:2000, Cell Signaling) antibody for 30 min. The membranes were washed with PBST, exposed to ECL reagents, and imaged. An image-analyzing system was then used to detect the density of bands with repeated measures (N = 4).
Superoxide dismutase (SOD) activity assay
SOD activity was evaluated using an SOD activity assay kit (Jiancheng Biotech, China) following the manufacturer protocol. Briefly, the tissue proteins were denatured at 95°C for 40 min, and centrifuged at 2000 g for 10 min. SOD was prepared by extraction with chloroform-ethanol (5:3, v/v), centrifugation and acetone precipitation. SOD activity was measured based on the xanthine oxidase method.
Determination of ROS
Pancreatic tissues were processed as described for the SOD assay, and incubated with 2',7'-dichlorofluorescein diacetate for 15 min. After incubation, the samples were centrifuged and the precipitated pellets were re-suspended in sterile PBS. Samples were then incubated at 37°C for 60 min. The ROS level was quantified by spectrometry and reported as percentage.
Statistical analysis
The data are reported as means ± standard deviation (SD). The SPSS 16.0 software was used to analyze all data. Analysis of variance (ANOVA) was used to compare the means across groups. A statistical significance was defined when P < 0.05.
RESULTS
Serum indices of rats
The levels of AMY, Cr, and ALT in the SAP model rat group were significantly higher than in the control group (Table 2; P < 0.05) after 12 h of SAP induction. The administration of pterostilbene significantly depressed these indices compared to the model group in a dose-dependent manner (Table 2 ; P < 0.05), although the indices were still higher than in the control group. *P < 0.05 compared to the control group; # P < 0.05 compared to the SAP group; r P < 0.05 compared to 20 mg/kg pterostilbene group. 
Effects of pterostilbene on inflammatory markers TNF-α and IL-1β
Serum levels of TNF-a and IL-1b were higher in the SAP model rats than in the control group (P < 0.05) as determined by ELISA. Pterostilbene significantly suppressed the expression of serum TNF-a and IL-1b in a dose-dependent manner (P < 0.05; Figure 1 ), although the expression was still higher than that in the control group. These results collectively suggested the role of pterostilbene in decreasing serum inflammatory cytokine secretion for alleviating inflammation in SAP. 
Effects of pterostilbene on NF-κB expression in pancreatic tissue
Real-time PCR showed that NF-kB expression was increased in the SAP rat pancreas than in the pancreas of control group rats (P < 0.05; Figure 2) . The pre-treatment with pterostilbene significantly inhibited NF-kB expression. However, at high dose it only marginally potentiated such inhibitory effects without statistical significance (P > 0.05; Figure 2) . 
NF-κB protein expression
Western blotting showed that NF-kB protein expression was consistent with the mRNA expression patterns. NF-kB protein was significantly up-regulated in SAP rats (P < 0.05; Figure  3 ). Pre-treatment with pterostilbene significantly inhibited NF-kB expression. However, this inhibition was not in a dose-dependent manner, as at high doses it only marginally potentiated such inhibitory effects without statistical significance (P > 0.05; Figure 3) . 
Oxidative stress indices
The ROS generation in SAP rats was significantly increased, whereas the SOD contents were decreased compared to in the control group (P < 0.05). The pre-treatment with pterostilbene significantly decreased the ROS production and increased the SOD contents in a dose-dependent manner (P < 0.05; Table 3 ). These results suggested that pterostilbene has potential of protecting pancreatic tissues during SAP by modulating oxidative stress and inhibiting the inflammatory response. *P < 0.05 compared to the control group; # P < 0.05 compared to the SAP group; r P < 0.05 compared to 20 mg/kg pterostilbene group. 
DISCUSSION
Among a series of pathological processes induced by SAP, systematic inflammatory response syndrome (SIRS), infectious necrosis, and multiple-organ failure are major factors causing death. Various studies have shown the occurrence of tissue edema, necrosis, and infiltration, all of which facilitate the release of inflammatory cytokines and reduce the expression of anti-inflammatory factors from lymphocytes, neutrophils, and macrophages, disrupt the body's immune balance, and lead to death by SIRS and multiple-organ failure (Liu et al., 2015; Meher et al., 2015) . Therefore, inflammation is the main pathological manifestation of SAP. As liver tissue may be severely damaged by SAP, enzymes synthesized in hepatocytes may be released in systemic circulation, causing elevated serum AMY, Cr, and ALT levels (Chen et al., 2015) . Consistent with these findings, serum indices and inflammatory cytokines were increased in SAP rats in the current study, suggesting higher inflammation, liver dysfunction, and imbalanced serum indices compared to the control group.
This study showed that pterostilbene decreased the serum levels of TNF-a and IL-1b, AMY, Cr, and ALT levels, decreased the ROS generation, and increased the SOD activity. It shows that pterostilbene may alleviate the SAP-related tissue injuries. Previous studies have shown that pterostilbene exerts ROS scavenging activity via antioxidant pathway, which modulates oxidation-reduction homeostasis. In addition, it shows efficacy against multiple diseases including ischemia-reperfusion damage, inflammation, and tumors. In vivo studies showed the effect of pterostilbene in reducing xanthine oxidase expression and improving ischemic injury of renal, testicular, muscular, ovarian, spinal cord, and brain tissues (Chen et al., 2015; El-Sayed et al., 2015) . Hence, the results of this study were consistent with previous studies. To the best of our knowledge, this is the first report of using pterostilbene as antiinflammatory agent against SAP. Endogenous antioxidation system continuously clears the ROS to protect tissues from oxidative injury. SOD is one of the most important antioxidative enzymes, which clear oxygen-free radicals. It plays a critical role in maintaining the body's balance of oxidation and antioxidation and its activity directly reflects the body's ability to clear free radicals (Wang et al., 2015c) . This study showed that pterostilbene reduced the oxidative injury in pancreatic tissues by up-regulating SOD that facilitated in ROS scavenging activity.
NF-kB exists silently in cytoplasm under normal circumstances. However, it is activated by transcriptional/translational factors under various stimuli such as inflammatory factors, signal transduction, reactive oxygen family, heavy metals, NO, and interleukins (Wang et al., 2015a) . Pterostilbene decreased the expression of NF-kB that reduced inflammation and ROS. However, whether the above changes lead to amelioration of AP inflammatory pathology after administration of pterostilbene was not determined, which could be the main limitation of the current study.
In summary, pterostilbene decreases the SAP-induced pancreatic tissue by alleviating inflammation and antioxidation functions.
